Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly
- PMID: 21402255
- DOI: 10.1016/j.ejim.2010.11.009
Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly
Abstract
Background: Proton pump inhibitors (PPI) are among the most commonly prescribed medicines and their overuse is widespread in both primary and secondary care. Inappropriate prescription is of particular concern among elderly patients, who have often multiple comorbidities and need many drugs.
Methods: We evaluate the appropriateness of drugs for peptic ulcer or gastro-esophageal reflux disease (GERD) in a sample of elderly patients (65 years old or older) at admission and discharge in 38 internal medicine wards between January 2008 and December 2008, according to the presence of specific conditions or gastro-toxic drug combinations.
Results: Among 1155 patients eligible for the analysis, 466 (40.3%) were treated with drugs for GERD or peptic ulcer were at hospital admission and 647 (56.0%) at discharge; 62.4% of patients receiving a drug for peptic ulcer or GERD at admission and 63.2% at discharge were inappropriately treated. Among these, the number of other drugs prescribed was associated with greater use of drugs for peptic ulcer or GERD, even after adjustment for age, sex and number of diagnoses at admission (OR 95% CI=1.26 (1.18-1.34), p=.0001) or discharge (OR 95% CI=1.11 (1.05-1.18), p=0.0003).
Conclusions: Prevalence of inappropriate prescription of drugs for peptic ulcer or GERD remained almost the same at admission and discharge. Inappropriate use of these drugs is related to the concomitant use of other drugs. Careful assessment of clinical conditions and stricter adherence to evidence-based guidelines are essential for a rational and cost-effective use of drugs for peptic ulcer or GERD.
Copyright © 2010 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people.Eur J Clin Pharmacol. 2020 Mar;76(3):459-465. doi: 10.1007/s00228-019-02815-w. Epub 2019 Dec 18. Eur J Clin Pharmacol. 2020. PMID: 31853593
-
[Assessment of inappropriate prescribing in the elderly subject during acute care hospitalisation].Geriatr Psychol Neuropsychiatr Vieil. 2011 Mar;9(1):51-7. doi: 10.1684/pnv.2011.0256. Geriatr Psychol Neuropsychiatr Vieil. 2011. PMID: 21586377 French.
-
The appropriateness of a proton pump inhibitor prescription.Ir Med J. 2014 Nov-Dec;107(10):326-7. Ir Med J. 2014. PMID: 25551900
-
Aging and upper gastrointestinal disorders.Best Pract Res Clin Gastroenterol. 2004;18 Suppl:73-81. doi: 10.1016/j.bpg.2004.06.015. Best Pract Res Clin Gastroenterol. 2004. PMID: 15588798 Review.
-
Latin american consensus on gastroesophageal reflux disease: an update on therapy.Gastroenterol Hepatol. 2010 Feb;33(2):135-47. doi: 10.1016/j.gastrohep.2009.05.007. Epub 2009 Aug 6. Gastroenterol Hepatol. 2010. PMID: 19664853 Review. No abstract available.
Cited by
-
The impact of proton pump inhibitors on brain health based on cross-sectional findings from the Rhineland Study.Sci Rep. 2024 Dec 16;14(1):30486. doi: 10.1038/s41598-024-81011-y. Sci Rep. 2024. PMID: 39681582 Free PMC article.
-
Proton pump inhibitors and dementia risk: Evidence from a cohort study using linked routinely collected national health data in Wales, UK.PLoS One. 2020 Sep 18;15(9):e0237676. doi: 10.1371/journal.pone.0237676. eCollection 2020. PLoS One. 2020. PMID: 32946449 Free PMC article.
-
A Cross-Sectional Study on Single-Day Use of Proton Pump Inhibitors in Tertiary Care Hospitals of South India.Hosp Pharm. 2021 Apr;56(2):109-115. doi: 10.1177/0018578719873876. Epub 2019 Sep 10. Hosp Pharm. 2021. PMID: 33790486 Free PMC article.
-
Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.Drugs Aging. 2013 Feb;30(2):103-12. doi: 10.1007/s40266-012-0044-x. Drugs Aging. 2013. PMID: 23239364
-
A benefit-risk assessment of the use of proton pump inhibitors in the elderly.Drugs Aging. 2014 Apr;31(4):263-82. doi: 10.1007/s40266-014-0166-4. Drugs Aging. 2014. PMID: 24634248 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical